TipRanks
Go Ultimate55% OFF

Blueberries Medical (1OA) Ownership - Who Owns Blueberries Medical?

Blueberries Medical (1OA) Ownership Overview

  • 78.60% Insiders
  • <0.01% Other Institutional Investors
  • 21.39% Public Companies and Individual Investors

The ownership structure of Blueberries Medical (DE:1OA) stock is a mix of institutional, retail, and individual investors. Approximately <0.01% of the company’s stock is owned by Institutional Investors, 78.60% is owned by Insiders, and 21.39% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Sep 28, 2026Guillermo Pablo Rodriguez$1,380
Aug 27, 2026Facundo GarretonC$1,095,000

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

DE:1OA top shareholders
Holder# of SharesType% HoldingValue
Facundo Garreton352,551,461Insider71.21%3,878,066
Guillermo Pablo Rodriguez36,613,909Insider7.40%402,753

FAQ

Who Owns Blueberries Medical (DE:1OA)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 78.60% is held by insiders, and 21.39% is held by public companies and individual investors.
What percentage of Blueberries Medical (DE:1OA) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Blueberries Medical (DE:1OA) stock is held by institutional investors.
What percentage of Blueberries Medical (DE:1OA) stock is held by retail investors?
According to the latest TipRanks data, approximately 21.39% of Blueberries Medical (DE:1OA) stock is held by public companies and individual investors.
Who owns the most shares of Blueberries Medical (DE:1OA)?
Facundo Garreton owns the most shares of Blueberries Medical (DE:1OA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.